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Competition between lymphocyte function-associated 
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binding to intercellular adhesion molecule-1 (CD54)
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Abstract: Both human integrin receptors Mac-1 
(C D llb /C D 18 , CR3) and lymphocyte function-asso­
ciated antigen (LFA)-l (CD 11 a/CD 18) have been  
demonstrated to bind human intercellular adhesion
m olecule-1 (ICAM-1) (CD54). Here we show that 
LFA-1 and Mac-1 can bind to ICAM-1 in the mouse 
as well. Interestingly, we observed that binding o f  
murine LFA-1 dominates over Mac-1 for binding to 
ICAM-1. Using three different murine macrophage 
cell lines that express distinct levels of LFA-1 and 
Mac-1 on their cell surface, we could only detect 
Mac-1 -dependent adhesion to ICAM-1 when little or 
no LFA-1 is expressed on the cell surface. When 
LFA-1 and Mac-1 are expressed at similar levels, the 
LFA-l/ICAM-1 interaction dominates over Mac- 
1/ICAM-1 interaction, indicating that there is a com ­
petition of LFA-1 and Mac-1 for ICAM-1 binding. J♦
Leukoc, Biol. 59: 648 -655; 1996.
K ey Words: regulation * p2 integrin • adhesion
INTRODUCTION
Both lymphocyte function-associated antigen-1 (LFA-1; 
CDlla/CD18) and Mac-1 (CDllb/CD18, CR3) are mem­
bers of the leukocyte-restricted P2 integrins. This group 
consists of the following three structurally related glyco­
proteins: LFA-1, Mac-1, and p i 50,95 (CDllc/CD18) [1,
2], The P2 integrins are heterodimers composed of a 
unique (X subunit with a molecular mass of 170, 165, and 
150 kDa (for LFA-1, Mac-1, and pl50,95 respectively) 
and a common P subunit of 95 kDa [3],
Whereas LFA-1 is expressed on all leukocytes [4], Mac- 
1 is predominantly expressed by cells of the monocytic 
lineage [4-8], In resting granulocytes Mac-1 is stored in 
peroxidase-negative granules. Upon addition of inflamma­
tory mediators degranulation occurs, leading to an in­
creased surface expression of Mac-1 molecules [8—11]. In 
addition, intracellular signals can activate ¡J2 integrins at 
the cell surface, which can be mimicked by Mn24* [12, 13] 
or by stimulating antibodies, that activate P2 integrin mole­
cules by altering the molecular conformation [14-17], 
LFA-1 is involved in distinct adhesion-dependent func­
tions such as T cell- mediated killing, T helper cell and B
I
cell responses, natural killer cell activity, monocyte-medi­
ated antibody-dependent cytotoxicity, and leukocyte adhe­
sion to endo the lia l cells [18, 19]. Mac-1 acts as a 
complement receptor but also mediates phagocytosis by 
activated macrophages and plays a role in adherence-de- 
pendent locomotion of neutrophils in the presence of 
chemoattractants [7, 20-22].
Intercellular adhesion molecule-1 (ICAM-1) is a cell- 
surface glycoprotein of 90-110 kDa and belongs to the 
immunoglobulin superfamily [23, 24]. It consists of five 
immunoglobulin-like domains [24]. Both human LFA-1 
and Mac-1 have been described to bind ICAM-1 (CD54) 
[25—28]. LFA-1 binds to the first immunoglobulin (Ig)-like 
domain of ICAM-1 [29, 30], whereas Mac-1 binds to a 
distinct site on the ICAM-1 molecule, the third Ig-like 
domain [30]. ICAM-1 is expressed on a wide range of 
hematopoietic and non-hematopoietic cells. Expression on 
unstimulated endothelial cells is low, but lipopolysaccha- 
ride, interleukin-1, and tumor n e c r o s is  factor-Ot rapidly 
up-regulate both mRNA and surface expression of ICAM-1
[31-33],
Apart from ICAM-1, other ligands for LFA-1 and Mac-1
have been described. LFA-1 can mediate cell adhesion by
binding to ICAM-2 [34] or ICAM-3 [35-38]. Mac-1 has
been reported to function as a receptor for the complement
component C3bi [7], factor X [39] and fibrinogen [40, 41]. 
LFA-1 [42], Mac-1 [43], and ICAM-1 [44] have all been
characterized in the mouse. Similar to the human system,
ICAM-1 has been defined as a ligand of LFA-1 in the 
mouse [44—46]. However, until now ligands of murine 
Mac-1 have not been studied in detail. We show here that 
ICAM-1 serves as a ligand for Mac-1 in the mouse as well. 
Furthermore, we studied the competition of LFA-1 and
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Mac-1 for binding ICAM-1 by comparing the adhesion of 
different mouse macrophage cell lines, expressing various
amounts of LFA-1 and Mac-1, to purified ICAM-1. •
MATERIALS AND METHODS
Monoclonal antibodies
The following monoclonal antibodies (mAb) directed against different 
murine adhesion molecules were used: M17.4 (anti-C D lla, lgG2a)
[47], H I54.163 (anti-C D lla, IgG2a, kindly provided by Dr. Pierres)
[48], M l/70.15 (anti-C D llb, IgG2b) [43], 5C6 (anti-C D llb, IgG2b, 
kindly provided by Martyn Robinson, Celltech) [4-9], M18.2 (anti-CD18, 
IgG2a) [50], YN1/1.7 (anti~CD54, lgG2b) [51], and R l-2  (anti-CD29d, 
VLA-4, lgG2b, kindly provided by Dr. Holzmann) [52].
Fab fragments and F(ab/)2 fragments of YNl/1.7 and 5C6 were pre­
pared as previously described [53], and analyzed by sodium dodecyl 
sulfale-polyacrylamide gel electrophoresis (SDS-PAGE) [54]»
Cells and culture conditions
The following three different cell lines were used: the murine macro­
phage cell lines CA5 (fusion product of J774 macrophage cells with 
spleen macrophage cells), 293, and 298 (BM12 bone marrow cells 
immortalized with Mic-virus and selected on their adhesive properties: 
293 cells adhere, 298 cells grow in suspension). All cells were grown in 
Iscove's medium (GIBCO) supplemented with 5% fetal calf seruin and 
1% antibiotics/antimycotics (GIBCO).
Isolation and purification of the antigens by affinity 
chromatography
Murine Mac-1 and ICAM-1 were purified by lysing 10 X 109 CAS cells, 
which expressed both Mac-1 and ICAM-1 at high levels. Isolation of the
antigens was performed at 4°C. Cells were lysed in lysis buffer contain­
ing 0.5% Triton X-100, 150 mM NaCl, and 10 mM triethanolamine. All
buffers used were supplemented with 1 mM phenyl-inethyl-sulfonyl-
fluoride (PMSF), 2 mM MgCl2, 1 mM CaCl2, and 50 |ltM sodium
vanadate.
For isolation of murine ICAM-1, purified Y N l/1.7 mAb was cova­
lently linked to CNBr-activated sepharose beads (Pharmacia, 5 rng/mL). 
For isolation of murine Mac-1 purified M l/70.15 mAb was covalently 
coupled to CNBr-aclivated sepharose beads (5 mg/mL). The affinity 
columns were sequentially washed with 5 volumes (corresponding to the 
volume of the column) of elution buffer (containing 1% p-D -octylglu-
coside, 400 mM NaCl, and 50 mM triethanolamine), pH 11 (1 mL/min) 
and 5 volumes of equilibration buffer (0.5% Triton X-100, 150 mM 
NaCl, and 50 mM triethanolamine) at pH 7.8 (1 mL/min). The lysate 
was pre-cleared by overnight incubation with rat IgG coupled to CNBr- 
activated sepharose beads and loaded onto the column (flow rate =  1 
mL/min). After loading, the column was sequentially washed with 5 
volumes of the equilibration buffer at pH 7.8 (1 inlVmin); 5 volumes of 
washing buffer {containing 0,1% Triton X-100, 150 inM NaCl, and 50 
mM triethanolamine) pH 7,8 (1 mL/min); and with 5 volumes of glycin 
buffer (1% p-D-octylglucoside, 150 mM NaCl, and 100 mM glycin) pH 
10 (1 mL/min). Elution of the antigen was carried out by 5 volumes of 
elution buffer at pH 11 (for Y N l/1 .7) or pH 12.5 (for M l/70.15) (1 inL/3
min). Fractions (0.5 mL) w ere  im m e d ia te ly  neu tra lized  by a d d in g
0.16%  1 M Tris’HCl/1% p -D -o c ty lg lu co s id e  pH 6.7, an d  were snap-fro- 
zen in l iq u id  n itro g en  a n d  s to re d  at -70°C.
Silver staining of the antigens
To determine the presence of antigens and its purity 25 flL of each 
fraction was analyzed by SDS-PAGE, using a 5-15% reducing gel. The 
gel was silver stained as described previously [55]. Purity of the isolated 
Mac-1 and ICAM-1 proteins was determined by enzyme-linked immu­
nosorbent assay (ELISA) in which the proteins were stained with either 
10 jag/mL anti-Mac-1 (5C6) or anti-ICAM-1 (YNl/1.7) mAh or anti-
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Fig. 1. Expression of LFA-1 and Mac-1 on murine macrophage cell lines. Cells were stained with control mAh, 
anti-LFA-1 (H I54.163), anti-Mac-1 (5C6), and anti-po (M18.2) followed by incubation with FITC-laheled mouse 
anti-rat-K IgG. (A-C) Expression of LFA-1 and Mac-1 on 298, 293, and CAS cells, respectively. One repre­
sentative experiment out of six is shown.
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lysates by centrifugation at 13,000 g. Subsequently, immunoprecipi- 
tates were washed extensively in IPB.
Electrophoresis and autoradiography
SDS-PAGE was carried out on vertical slab gels (5-15%) according to 
a modification of the Laemli procedure [54]. Samples were analyzed 
under reducing conditions with 5% 2-j3-mercaptoethanol in SDS sample 
buffer. Kodak XAR-film was used in combination with intensifier 
screens (Cronex Lightning Plus; Dupont Chemical Co., Newton, CT) for 
autoradiography of I-labeled materials.
Ceil binding to purified antigens
Purified murine ICAM-1 and Mac-1 (10-30 ng) was coated overnight at
4°C in TMS (20 mM Tris-HCl pH 8 ,1 5 0  mM NaCl, 1 mM CaCh, 2 mM
MgCte) on 96-well microtiter plates (Costar, Cambridge, MA). As pro­
tein control 100 |lL of 40 |Ig/mL collagen type I (Sigma) was coated 1 
h at 37°C. Fibrinogen type I (Sigma) and BSA (Fraction V, Boehringer- 
Mannheim) was coated (100 }lL) in a concentration of 4-0 JJ.g/mL or 20 
mg/mL, respectively. Antigen-coated and control wells were blocked
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Fig. 2. Immunoprécipitation of LFA-1 and Mac-1 from the macrophage 
cell lines 298 (lanes A-C), 293 (lanes D-F), and CA5 (lanes G—J) with 
anti-LFA-1 (M17.4; lanes A, D, and G), anti-Mac-1 (Ml/70.15; lanes B, 
E, and H), anti-p2 (M18.2) mAb (lanes C, F, and I) or with normal rat 
serum (lane J). The proteins precipitated were analyzed on a 5-15%  
SDS-PAGE under reducing conditions, The migration of the molecular 
weight markers is indicated on the left. Similar results were obtained in 
two other experiments.
LFA-1 (M17.4) mAb as a control for contamination. Peroxidase-labeled 
rabbit anti-rat IgG was used as second antibody and S ^ S ^ -te tr a -  
methyl-benzidine (Sigma Chemical Co., St. Louis, MO) as substrate. The 
optical density (0D) was measured at 450 nm.
Immunofluorescence
Cells were incubated (30 min, 4°C) in phosphate-buffered saline, con­
taining 0.5% wt/vol bovine serum albumin (BSA) and 0.01% sodium 
azide, with appropriate dilutions of the different mAb, followed by incu­
bation with fluorescein isothiocyanate FITC-labeled mouse anti-Rat-K 
IgG mAb (Sanbyo, Uden, The Netherlands) for the murine cell lines for 
30 min at 4°C. The relative fluorescence intensity was measured by 
FACScan analysis (Becton Dickinson, Oxnard, CA).
Radiolabeling and immunoprécipitation
125Cells were surface labeled with Na I (Amersham, Buckinghamshire, 
UK) through the lactoperoxidase method [56], For immunoprécipitation, 
CA5 cells (1 X 10 ) were lysed for 1 h at 4°C in immunoprécipitation 
buffer (IPB), which contained 1% NP-40, 50 mM triethanolamine (pH 
7.8), 150 mM NaCl, 5 mM ethylenediaminetetraacetate (EDTA), and as 
protease inhibitors, 1 mM PMSF, ovomucoid trypsin inhibitor (0.02 
mg/mL, Sigma), 0.02 mg/mL leupeptin, and 1 mM Nd-P-tosyl-L-lysine 
chloromethyl ketone were added, Nuclear debris was removed from the 
lysates by centrifugation at 13,000 g  for 15 min at 4°C. Lysates were 
pre-cleared by successive incubation with rat IgG coupled via rabbit- 
anti-rat IgG to protein A-sepharose CL-4B beads (Pharmacia Fine 
Chemicals, Piscataway, NJ). Pre-cleared lysates were incubated for 2 -3  
h with a specific mAb coupled via rabbit-anti-rat IgG to protein A- 
sepharose CL-4B. The immunoprecipitates were removed from the
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Fig. 3 . SDS-PAGE of purified murine Mac-1 and ICAM-1. Twenty-five 
microliters of purified murine Mac-1 and ICAM-1 was electrophoresed 
on a 5-15%  gradient SDS-PAGE under reducing conditions and sub­
jected to silver staining. Migration of the molecular weight markers is 
represented on the left. Lane A: purified murine Mac-1 (165/95 kDa). 
Lane B: purified murine ICAM-1 (105 kDa). One representative experi­
ment out of three is shown.
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wilh 0.01% wt/vol gelatin in TMS for 30 min at 37°C, after which they 
were washed twice with Iscove’s medium supplemented with 0.5% 
wt/vol BSA and 1% antibiotics/antimycotics. After labeling of the cells 
with Na2S1Cr04 for 4-5-60 min at 37°C, ceils were pre-incubated with 
10% normal rat serum for 15 min at room temperature (RT) and sub­
sequently washed Lwice with medium. Radiolabeled cells ( 2 x 1 0  ) were 
allowed to adhere for 2 0 -3 0  min at 37°C. Unbound cells were removed 
by washing with Iscove's medium. The adherent cells were lysed with 
100 JlL of 2% Triton X-100 and radioactivity was quantified in a gamma 
counter. Results are expressed as the mean percent of cell binding from 
duplicate wells or as relative inhibition of total adhesion of duplicate 
wells.
When indicated, EDTA was added in a final concentration of 5 mM. 
Antibodies were added in a final concentration of 1 0 -5 0  |ig/mL.
RESULTS
Expression of LFA-1 and Mac-1 on distinct 
macrophage cell lines
To determine the capacily of LFA-1 and Mac-1 to bind 
ICAM-1, we first investigated the expression level of these 
different adhesion receptors on three distinct murine
macrophage cell lines (298, 293, and CA5). Immunofluo­
rescence studies showed that all cells express equal levels 
of the P2 integrins (M18.2). Staining the cells with specific 
anti-LFA-1 or anti-Mac-1 mAb revealed that both 298 
cells  and CA5 cells expressed high levels of LFA-1, 
whereas 293 expressed low levels of LFA-1. In contrast, 
high Mac-1 expression was only observed on 293 and CA5 
cells (Fig. 1).
These findings were confirmed by immunoprecipitation 
studies (Fig. 2). As expected, LFA-1 but not Mac-1 could 
be precipitated from the 298 cells (Fig. 2, lanes A and B). 
Only minute amounts of LFA-1 could be precipitated from 
293 cells, whereas Mac-1 was precipitated in large quan­
tities (Fig. 2, lanes D and E). In contrast, equal amounts of 
LFA-1 and Mac-1 were precipitated from the CAS cells 
(Fig. 2, lanes G and H).
Isolation of murine Mac-1 and ICAM-1
To investigate the interaction of Mac-1 with ICAM-1 in the 
mouse, we isolated both murine ICAM-1 and Mac-1 from 
the murine macrophage cell line CAS (see MATERIALS 
AND METHODS). Fractions collected after elution from 
the ICAM-I (YN1/1.7) and the Mac-1 (Ml/70.15) affinity
column were analyzed by SDS-PAGE and silver staining 
(Fig. 3). The fractions eluted from the Mac-1 column con­
tained the complete 0t/(3 complex, with an (X chain of 165 
kDa and a (3 chain of 95 kDa (lane A), whereas the ICAM- 
1 antigen with a mass of 105 kDa was eluled from the 
ICAM-1 column (lane B). In an ELISA detection system no 
contamination of LFA-1 in the purified Mac-1 fraction was 
observed (Table 1; OD450 with anti-LFA-1 mAb is <
0.065). The purity of both Mac-1 and ICAM-1 proteins was
> 9 5 % .
TABLE 1. Purity of Isolated Mac~l Protein as Measured by an 
__________________Antigen-Specific ELISA_________________
Dilution of purified 
Mac-1 protein
OD450 with anü-M ac-l 
mAh (5C6)
OD450 with anti-LFA-1 
mAb (M17.4)
1:25 1.161 0.04-5
1:50 1.176 0.038
1:100 1.191 0.025
1:200 1.106 0.032
1:400 0.757 0.050
1:800 0.377 0.065
1:1600 0.204 0.028
Mac-1- and LFA-1-mediated adhesion to murine 
ICAM-1
Human Mac-1 has been described to bind human ICAM-1 
[27, 30]. To test whether murine Mac-1 also binds murine 
ICAM-1, we allowed Mac-1-expressing cells to bind to 
coated purified murine ICAM-1. For this purpose we used 
the murine macrophage cell lines CAS, 293, and 298,
expressing distinct levels of Mac-1 on their cell surfaces 
(Figs. 1 and 2). Because these cell lines expressed variable 
levels of LFA-1 and Mac-1, we could investigate whether 
LFA-1 and Mac-1 compete for binding to ICAM-1.
All three macrophage cell lines bound to ICAM-1 
equally well (15-35% ; Fig. 4 , A-C). Pre-incubation of 
the cells with EDTA resulted in a complete inhibition of 
adhesion of the different celt lines to ICAM-1, which indi­
cates that the adhesion to ICAM-1 is integrin dependent 
(data not shown). Binding was specific, since no binding of 
control protein collagen type I was observed (< 5%). The 
adhesion of the cells to ICAM-1 was not further increased 
upon addition of Mn2+, which is known to stimulate inte- 
grin-mediated adhesion. This finding indicates that the 
integrins expressed by these cells were already in an acti­
vated state (data not shown).
Adhesion of 298 cells to ICAM-1 was completely LFA-1 
dependent (Fig. 4, A and D), which corresponds with the 
observation that 298 cells express only LFA-1, No block of 
adhesion was observed when 298 cells were incubated 
with an anti-Mac-1 (5C6) mAb, or a control mAb (R l-2) 
directed against VLA-4. In contrast, 293 cells (Fig. 4, C 
and D) adhered predominantly via Mac-1 to ICAM-1 (82% 
block with the anti-Mac-1 mAb 5C6), which corresponds 
to the high expression of Mac-1 and a low expression of 
LFA-1 on these cells. Adhesion of CAS cells, which ex­
press as much LFA-1 as the 298 cells, and similar levels 
of Mac-1 as the 293 cells, could only be blocked by anti- 
LFA-1 mAb (57%) and not by anti-Mac-1 mAb alone (Fig. 
4, B and D). A small Mac-1- dependent component of 14% 
was only observed when anti-Mac-1 and anti-LFA-1 mAb 
were combined (Fig. 4, B and D). The inability of Mac-1 
to bind ICAM-1 was not caused by a defective or inactive 
form of Mac-1 expressed by CA5 cells, since CAS cells 
showed strong M ac-l-m ediated  adhesion to fibrinogen
(Fig. 5A) and BSA (Fig. SB), two other ligands of Mac-1. 
These findings indicate that, when both LFA-1 and Mac-1
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F ig. 4 .  LFA-1- and Mac-l-dependent adhesion to purified murine ICAM-1. 51Cr-labeled macrophage cells 298 (A), CAS (B), and 293 (C) were 
incubated for 15 min at RT with either no mAb or 10 Jig/mL anti-LFA-1 (H 154.163), 10 |Ig/mL anti Mac-1 (5C6) or both mAb combined. Cells were 
allowed to bind to purified murine ICAM-1 (10-30 ng) for 20 min at 37°C. The different cell lines bound for 15-35%  to ICAM-1. (D) Relative LFA-1- 
and Mac-l-dependent adhesion. The LFA-l-mediated adhesion was determined by incubating cells with 10 |ig/mL anti-LFA-1 mAb (H154.163). The 
Mac-l-dependent binding was determined by the difference in inhibition between cells incubated with both 10 JIg/mL anti-Mac-1 (5C6) and 10 (Ig/mL 
anti-LFA-1 mAb and cells incubated with 10 |ig/mL anti-LFA-1 mAb alone. The relative percentage of adhesion observed when only anti-Mac-1 mAb 
was added, was 0, 0, and 82%  for 298, CAS, and 293, respectively. (E) Actual percentage of adhesion of 2 98, CAS, or 293 cells to ICAM-1 in the 
presence (filled bars) or absence (hatched bars) of 50 |ig/mL Fab fragments of anti-ICAM-1 mAb (YNl/1.7~Fab). (F) Relative percentage inhibition of 
adhesion of 298, CA5, and 293 to purified murine ICAM-1. Cells were incubated with 50 |lg/mL Fab fragments of anti-ICAM-1 mAb (YN1/1.7-Fab). 
Experiments were carried out in duplicate (SD< 4%). Adhesion to protein control was always <  2%. One representative experiment out of three is 
shown.
are equally expressed on the cell surface, LFA-1 domi- ICAM-1-mediated adhesion to murine Mac-1 
nates over Mac-1 for binding ICAM-1 (Fig. 4D).
To demonstrate that adhesion was specifically mediated To demonstrate that the lack of Mac-l-mediated ICAM-1
by ICAM-1, we blocked the interaction of the distinct cell binding by CAS cells is not due to expression of an inactive
lines  using Fab fragments of the anti-ICAM-1 mAb form of Mac-1 by these cells, we isolated Mac-1 protein
YN1/1.7, which is known to block the LFA-l/ICAM-1 in- from these cells (Fig. 3) and also tested the capacity of
teraction [57]. Fab fragments were used to prevent Fc-me- cell-bound ICAM-1 to bind to this purified murine Mac-1
diated binding of the macrophage cells to ICAM-1 (Fig. 4, 
E and F). Anti-ICAM-1 mAb completely blocked the adhe­
sion of 298 cells to ICAM-1, whereas it partially blocked
the adhesion of 293 and CA5 cells to ICAM-1. EDTA
protein. Purified murine Mac-1 antigen was functional, 
since CAS cells that express high levels of murine ICAM-1 
readily bound to coated purified Mac-1 antigen (Fig. 6). 
Due to Fc receptor expression on the murine macrophage
completely blocked the interaction of all three cell lines to cell lines, F f a b ^  fragments of anti-Mac-1 mAb (5C6) were 
ICAM-1 (data not shown), indicating that the adhesion was used to inhibit the binding. Partial inhibition (50-60%) of
specific for integrins (Fig. 4). CA5 cells to Mac-1 was observed, demonstrating that ad-
6 5 2  Journal of Leukocyte Biology Volume 59, May 1996
A 30
control YN1/1.7 SC6 5C6-F(ab'), EDTA
B 30-
©
8
■<!
control YN1/1.7 5C6 5C6-F(ab'), EDTA
Fig. 5. Functional activity of Mac-1 on CA5 cells, Adhesion of CA5 cells 
to purified fibrinogen (A) and BSA (B). DlCr-labeled macrophage cells 
(CA5) were incubated with mAb for 15 min at RT and were allowed to 
bind to purified murine fibrinogen type I (40 Jig/mL) for 20 min at 37°C 
(A) or to BSA (20 mg/mL; B). Adhesion was inhibited by addition of 10 
fj-g/mL anti-ICAM-1 (YN1/1.7) mAb, 10 [ig/mL anti-Mac-1 (5C6) mAb, 
50 ]lg/mL F(ab')2 fragments of the anti-Mac-1 (5C6) mAb or EDTA (5 
mM). Experiments were canned out in triplicate (SD < 4% ) and 20-25%  
of the CA5 cells bound purified fibrinogen and BSA. One experiment out 
of three is shown.
hesion is Mac-1 dependent (maximal inhibition obtained 
with 5C6-F(ab/)2 is 50%, since F(ab')2  fragments are less 
efficient than complete IgG [49], As expected, EDTA com­
pletely abrogated binding, showing that adhesion of CAS 
cells was integrin mediated (Fig. 6).
DISCUSSION
In this study we investigated the interaction of Mac-1 with 
ICAM-1 in the mouse. The following two major conclusions 
can be drawn: (1) we have shown that ICAM-1 is a ligand 
for Mac-1 in the mouse as well; (2) by comparing the
Mac-l/ICAM-1 with the LFA-l/ICAM-1 interaction on 
cells expressing both LFA-1 and Mac-1, we observed that 
LFA-1 and Mac-1 compete for binding to ICAM-1, and that 
LFA-1 dominates over Mac-1.
Although both 293 and CA5 cells express equal amounts 
of Mac-1, only 293 cells showed a M ac-l-dependent adhe­
sion to ICAM-1. The observation that Mac-1 on CAS cells 
was unable to bind to ICAM-1 was not the result of an 
inactive Mac-1 receptor, since the same cells showed Mac-
l-dependent adhesion to solid-phase fibrinogen and BSA, 
two other ligands of Mac-1 (Fig. 5) [40, 41]. These results 
suggest that when both LFA-1 and Mac-1 are present on 
the cell surface, ICAM-1 preferentially binds to LFA-1. 
Furthermore, preliminary data show a cross-species inter­
action of human Mac-1 with murine ICAM-1 (data not 
shown). This cross-species interaction of Mac-1 with
ICAM-1 is, similar to the LFA-l/ICAM-1 [58], unidirec­
tional. The cross-species interaction of Mac-1 to murine 
ICAM-1 was only detected when LFA-1- mediated adhe­
sion was blocked. This indicates that the preference of 
ICAM-1 to bind to LFA-1 rather than to Mac-1 also exists 
across the species barrier (data not shown).
Until now, the mechanism underlying the preference for 
LFA-l/ICAM-1 interaction is not known. However, the 
data presented in this article suggest that ligand occupa­
tion by LFA-1 may result in the generation of intracellular 
signals that may lead to a selective inactivation of the 
Mac-1 receptor. We cannot exclude the possibility that a 
higher affinity of LFA-1 compared with Mac-1 may also 
account for the preference for LFA-1 to bind ICAM-1. 
Although this is unlikely, since a lower percentage of LFA- 
1- expressing cells (in absolute numbers; Fig. 4A), com­
pared to M ac-l-expressing cells, bound to ICAM-1 {Fig. 
4C). Potential differences in affinity between LFA-1 and 
Mac-1 for binding ICAM-1 might be measured in a Bia- 
core/surface plasmon resonance setting and more experi­
ments are required to unravel the precise mechanism that 
may account for the preference for LFA-l/ICAM-1 interac­
tion. The notion that integrin receptors are selectively used 
by a cell to bind ligand is further supported by our pre­
vious observation that LFA-1 can also dominate over VLA- 
4 in binding of activated T cells to endothelium. In this 
particular case ligand binding by p2 integrins seem to 
down- regulate (3] integrin-mediated adhesion [59].
Fig. 6 . Binding of murine ICAM-1 to purified murine Mac-1. 3lCr-la- 
beled CA5 cells were incubated with mAb for 15 min at RT and were 
allowed to bind to purified murine Mac-1 (10-30 ng) for 30 min at 37°C. 
The adhesion was inhibited by addition of 10 Jig/mL anti-ICAM-1 
(YN1/1.7) mAb, 50 Jlg/mL anti-Mac-1 [SCó-Fiab^] mAh or EDTA (5 
mM), Experiments were carried out in duplicate (SD< 4%) and 20% of 
the CA5 cells bound purified Mac-1. One experiment out of three is 
shown.
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Similar to ICAM-1, the extracellular matrix components 
fibronectin and laminin can also bind more than one inte­
grin [60], Binding of the same ligand by multiple integrins 
may be functionally important since attachment of that 
ligand by different integrins may result in distinct intracel­
lular signals.
Several reports indicate that glycosylation of ICAM-1 
may affect adhesion of Mac-1 to ICAM-1 [30, 61]. It has 
been shown that, when ICAM-1 transfectants are treated 
with an deoxymannojirimycin, which disrupts Golgi-asso- 
ciated N-linked carbohydrate addition, adhesion to puri­
fied Mac-1, but not to LFA-1 is improved. This enhanced 
adhesion is caused by the accumulation of N-linked oli­
gosaccharides in a high mannose form [61]. Thus the level 
and type of N-linked glycosylation on ICAM-1 may con­
tribute to the regulation of integrin-mediated adhesion: 
myeloid cells may accumulate if ICAM-1 is relatively de­
glycosylated, whereas lymphocytes may localize if ICAM-1 
is more abundantly glycosylated [30]. In our experiments 
we can detect both LFA-1 (298)- and Mac-1 (293)-de­
pendent adhesion to purified ICAM-1, indicating that 
ICAM-1 is properly glycosylated for both LFA-1 and Mac- 
1 interactions. Adhesion assays of cells expressing both 
LFA-1 and Mac-1 to deglycosylated ICAM-1 will deter­
mine whether this may affect the dominance of LFA-1 over
Mac-1 for binding ICAM-1.
Because macrophage cells express high levels of Fc re­
ceptors on their cell surface, F(ab, )2 fragments of an anti- 
Mac-1 mAb (5C6) were used to inhibit adhesion of the 
macrophage cells to purified Mac-1. Complete IgG of mAb 
5C6 efficiently inhibited the interaction of Mac-1 with pu­
rified ICAM-1 (Fig. 4D, cell line 293, 80% inhibition). 
However, binding of ICAM-1-expressing cells to purified 
Mac-1 was only partially blocked with F(al/ ) 2  fragments of
mAb 5C6 (60%), whereas Fab fragments of mAb 5C6 or 
mAb Ml/70.15 were ineffective. The lower inhibition by 
F(ab ')2  fragments of mAb 5C6 may be due to a somewhat 
lower affinity of F(ab ')2 fragments of mAb 5C6 for Mac-1 
[49]. Using the anti-ICAM-1 mAb YN1/1.7, we observed 
that this mAb was unable to block the Mac-l/ICAM-1 in­
teraction (Fig. 4E, CAS and 293), while it strongly inhib­
ited LFA-l/ICAM-1 interaction (Fig. 4A, 298). Taking into
account the high homology between mouse and human 
ICAM-1, it is most likely that YN1/1.7 bound to the first 
domain of ICAM-1 and therefore only inhibited LFA-l-me- 
diated adhesion. Until now no anti-ICAM-1 antibodies 
have been described that inhibit the Mac-l/ICAM-1 inter­
action in the mouse. Such mAb would be useful to investi­
gate the contribution of Mac-l/ICAM-1 in both in vitro as 
well as in vivo cell-cell interactions in more detail.
We have demonstrated by using purified murine ICAM- 
1 and Mac-1 as a substrate, that ICAM-1 is a ligand for 
Mac-1 in the mouse. Furthermore we have shown that 
LFA-1 competes with Mac-1 for binding to ICAM-1, dem­
onstrating a preference of ICAM-l/LFA-1 binding, when 
both adhesion receptors are functionally expressed on the 
cell surface. The importance of this preference remains to 
be established in vivo.
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